Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn
G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Tückischen Blutkrebs effektiv bekämpfen - Centrum für Integrierte Onkologie
Team | IMMEI
Auszeichnung für herausragende Krebsforscher – Innovations Report
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
Immunotherapy as an advance in cancer medicine - Innovations Report
Frontiers | Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
CIO Bonn - Tumorboards
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
